Submit a Press Release | About | Blog | Help | Pricing & Sign Up
Over 30,000 companies use PR LEAP Learn More
Dr. Raymond Stein and the Bochner Eye Institute team offer advanced C3R keratconus treatment.
(PRLEAP.COM) TORONTO, Ontario - March 2, 2009 - The Bochner Eye Institute is the among the first facilities in Canada to perform the advanced corneal collagen cross linking with riboflavin treatment for keratoconus. Corneal collagen cross linking with riboflavin, also referred to as C3R, prevents the cornea from bulging and becoming irregular. Studies have shown that C3R stops the progression of keratoconus and boasts a high safety record.
Raymond Stein, M.D., of the Bochner Eye Institute specializes in this advanced procedure and has published an article about C3R, which was featured in Eye Care Review. Patients under Dr. Raymond Stein’s care have slowed the progression of keratoconus, deferred the need for corneal transplants and lessened nearsightedness and astigmatism associated with keratoconus. In addition to his keratoconus treatment expertise, Dr. Raymond Stein is an innovator in refractive and implant surgery.
About the Bochner Eye Institute
The Bochner Eye Institute is a leading LASIK Toronto facility that boasts more than 80 years of eye care excellence. The surgical team of Dr. Raymond Stein, Dr. Harold Stein, Dr. Albert Cheskes and Dr. Jordan Cheskes have performed more than 100,000 procedures and completed their medical training at the world-renowned Mayo Graduate School of Medicine.
Contact Information
About This News Release
If you have any questions regarding information in these press releases please contact the organization listed in the press release. Issuers of press releases and not PR Leap are solely responsible for the accuracy of the content.
